47 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Medtronic (MDT) Wins CE Mark for MiniMed 780G With Simplera Sync https://www.zacks.com/stock/news/2208083/medtronic-mdt-wins-ce-mark-for-minimed-780g-with-simplera-sync?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208083 Jan 10, 2024 - Medtronic (MDT) secures the CE Mark for the MiniMed 780G system with the disposable, all-in-one Simplera Sync CGM.
Here's Why You Should Retain Charles River (CRL) Stock Now https://www.zacks.com/stock/news/2209712/here-s-why-you-should-retain-charles-river-crl-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2209712 Jan 12, 2024 - Investors are optimistic about Charles River (CRL) owing to growth in the RMS and DSA segments and stable solvency position.
Here's Why Investors Should Retain Bruker (BRKR) Stock Now https://www.zacks.com/stock/news/2210890/here-s-why-investors-should-retain-bruker-brkr-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2210890 Jan 16, 2024 - Investors are optimistic about Bruker (BRKR) on solid prospects of BSI Nano group and raised guidance.
Here's Why Investors Should Retain ResMed (RMD) Stock for Now https://www.zacks.com/stock/news/2211621/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2211621 Jan 17, 2024 - Investors are optimistic about ResMed (RMD) on strong uptake of the myAir app with AirSense11.
3 Medical Services Stocks to Buy Amid Industry Headwinds https://www.zacks.com/commentary/2224052/3-medical-services-stocks-to-buy-amid-industry-headwinds?cid=CS-ZC-FT-industry_outlook-2224052 Feb 09, 2024 - The Zacks Medical - Services industry is growing on digital healthcare adoption. ELV, COR and HQY are set to gain the most. However, staffing shortages continue to disrupt the growth trend.
Why HealthEquity (HQY) is Poised to Beat Earnings Estimates Again https://www.zacks.com/stock/news/2232650/why-healthequity-hqy-is-poised-to-beat-earnings-estimates-again?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_7-2232650 Feb 27, 2024 - HealthEquity (HQY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why HealthEquity (HQY) is a Top Momentum Stock for the Long-Term https://www.zacks.com/stock/news/2234658/why-healthequity-hqy-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2234658 Mar 01, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick https://www.zacks.com/stock/news/2241382/are-you-a-growth-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2241382 Mar 15, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Retain HealthEquity (HQY) Stock Now https://www.zacks.com/stock/news/2242869/here-s-why-you-should-retain-healthequity-hqy-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242869 Mar 19, 2024 - HealthEquity's (HQY) strength in HSAs raises optimism about the stock.
HealthEquity (HQY) Reports Q3 Earnings: What Key Metrics Have to Say https://www.zacks.com/stock/news/2193838/healthequity-hqy-reports-q3-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2193838 Dec 05, 2023 - While the top- and bottom-line numbers for HealthEquity (HQY) give a sense of how the business performed in the quarter ended October 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Pages: 12345

<<<Page 3>